Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia
Primary Purpose
Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
dCBT-I
Sponsored by
About this trial
This is an interventional treatment trial for Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
Eligibility Criteria
Inclusion Criteria:
- Age 18-40 years old
- 20-32 weeks of pregnancy, singleton pregnancy and regular obstetric examination at Zhejiang University Women's Hospital
- There has been a high frequency of insomnia symptoms
- According to the preliminary assessment by the project team, it meets the diagnostic criteria for insomnia
- Possess a smart phone and can operate it proficiently, with normal reading and writing comprehension ability, clear consciousness, and able to cooperate with the research to complete the questionnaire independently.
Exclusion Criteria:
- Assess the risk of preterm birth and concurrent pregnancy-related diseases;
- Completion of the 7-day sleep diary in the baseline period < 4 days;
- Combined with severe anxiety/depression;
- Suicidal tendencies or severe mental illness (bipolar disorder, schizophrenia, paranoid psychosis, etc.);
- Edinburgh Pregnancy Depression Scale (EPDS) total score ≥ 15;
- Have drug dependence or have taken anti-anxiety, anti-depression, sedative or hypnotic drugs for mental diseases within the past 3 months;
- Participated in interventions such as meditation courses, childbirth yoga or cognitive behavioral therapy in the past 1 year;
- Complicated with serious physical diseases such as heart failure and tumor;
- Combined with sleep disorders such as severe obstructive sleep apnea that require further evaluation and treatment;
- There is alcohol and cigarette dependence;
- Shift work;
- Severe visual or hearing impairment and unable to use mobile phones normally;
- Physical illness with unstable condition, or illness itself that may interfere with cognitive behavioral therapy for insomnia.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
dCBT-I treatment group
Arm Description
Outcomes
Primary Outcome Measures
Change of "Insomnia Severity Index(ISI)"
Insomnia Severity Index(ISI),the minimum and maximum values are 0 and 28, and higher scores mean a worse outcome.
Secondary Outcome Measures
Change of "Pittsburgh Sleep Quality Index(PSQI)"
Pittsburgh Sleep Quality Index(PSQI),the minimum and maximum values are 0 and 21, and higher scores mean a worse outcome.
Change of "sleep onset latency(SOL)"
simple questionnaire will be used to assess this outcome of sleep onset latency(SOL)
Change of "wake up after sleep onset(WASO)"
simple questionnaire will be used to assess this outcome of WASO
Change of "sleep efficiency(SE)"
combination of questionnaire and calculate will be used to assess this outcome of SE
Change of "Number of wake ups during the night"
Number of wake ups during the night
Change of "total sleep time(TST)"
total sleep time(TST)
Change of "Edinburgh Pregnancy Depression Scale(EPDS)"
Edinburgh Pregnancy Depression Scale(EPDS),the minimum and maximum values are 0 and 30, and higher scores mean a worse outcome.
Change of "Self-rating Anxiety Scale(SAS)"
Self-rating Anxiety Scale(SAS), the minimum and maximum values are 25 and 100, and higher scores mean a worse outcome.
Full Information
NCT ID
NCT05395546
First Posted
May 16, 2022
Last Updated
May 24, 2022
Sponsor
Women's Hospital School Of Medicine Zhejiang University
1. Study Identification
Unique Protocol Identification Number
NCT05395546
Brief Title
Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia
Official Title
Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia During Pregnancy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 1, 2022 (Anticipated)
Primary Completion Date
July 15, 2022 (Anticipated)
Study Completion Date
June 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Women's Hospital School Of Medicine Zhejiang University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Insomnia symptoms are common during pregnancy, especially in the second and third trimesters, which can reach more than 68%. Insomnia during pregnancy is not only associated with increased risk of preeclampsia, gestational diabetes, preterm labor, and cesarean section, but also increased postpartum poor sleep and postpartum depression. Cognitive behavioral therapy (CBT-I) and drug therapy for insomnia are the two main methods of insomnia treatment. Drug therapy is the more commonly used traditional treatment method, but there may be certain drug risks. Therefore, non-drug methods for Insomnia in pregnant women is much safer.
Cognitive-behavioral therapy for insomnia is a psychological therapy for insomnia. Compared with sedative-hypnotic drugs, its therapeutic effect is slow, but the curative effect is long-lasting, with less relapse after treatment and no invasive side effects. Multiple guidelines recommend it as first-line therapy for insomnia. And "Digital Cognitive Behavioral Therapy" (dCBT-I), is based on CBT-I, a therapy provided by the Internet and smartphones, which simulates face-to-face CBT-I in reality. It can provide more convenient medical services for the special group of pregnant women, improve sleep, improve mental symptoms, life treatment, and reduce the risk of adverse outcomes for mothers and children.
The Womens' Hospital, Zhejiang University School of Medicine is conducting a clinical study on "Digital Cognitive Behavioral Therapy (dCBT-I) for maternal Insomnia during pregnancy". The primary goal of this research project was to examine the efficacy of dCBT-I ("RuMian") in the treatment of maternal insomnia. "RuMian" is a fully automatic dCBT-I application developed in China, and subjects will use it for free.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
dCBT-I treatment group
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
dCBT-I
Other Intervention Name(s)
Device: smartphone
Intervention Description
Complete the evaluation of various scales and record a 7-day sleep diary before entering the group
Receive a 6-week treatment after enrollment, insist on using the app every day (about 5-10 minutes), and receive regular follow-up from the project doctor
Scale assessment needs to be completed at the end of treatment
One month after the end of treatment, cooperate with relevant follow-up and complete the scale evaluation
Primary Outcome Measure Information:
Title
Change of "Insomnia Severity Index(ISI)"
Description
Insomnia Severity Index(ISI),the minimum and maximum values are 0 and 28, and higher scores mean a worse outcome.
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Secondary Outcome Measure Information:
Title
Change of "Pittsburgh Sleep Quality Index(PSQI)"
Description
Pittsburgh Sleep Quality Index(PSQI),the minimum and maximum values are 0 and 21, and higher scores mean a worse outcome.
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "sleep onset latency(SOL)"
Description
simple questionnaire will be used to assess this outcome of sleep onset latency(SOL)
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "wake up after sleep onset(WASO)"
Description
simple questionnaire will be used to assess this outcome of WASO
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "sleep efficiency(SE)"
Description
combination of questionnaire and calculate will be used to assess this outcome of SE
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "Number of wake ups during the night"
Description
Number of wake ups during the night
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "total sleep time(TST)"
Description
total sleep time(TST)
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "Edinburgh Pregnancy Depression Scale(EPDS)"
Description
Edinburgh Pregnancy Depression Scale(EPDS),the minimum and maximum values are 0 and 30, and higher scores mean a worse outcome.
Time Frame
From before treatment to the end of treatment (an average of 42 days)
Title
Change of "Self-rating Anxiety Scale(SAS)"
Description
Self-rating Anxiety Scale(SAS), the minimum and maximum values are 25 and 100, and higher scores mean a worse outcome.
Time Frame
From before treatment to the end of treatment (an average of 42 days)
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-40 years old
20-32 weeks of pregnancy, singleton pregnancy and regular obstetric examination at Zhejiang University Women's Hospital
There has been a high frequency of insomnia symptoms
According to the preliminary assessment by the project team, it meets the diagnostic criteria for insomnia
Possess a smart phone and can operate it proficiently, with normal reading and writing comprehension ability, clear consciousness, and able to cooperate with the research to complete the questionnaire independently.
Exclusion Criteria:
Assess the risk of preterm birth and concurrent pregnancy-related diseases;
Completion of the 7-day sleep diary in the baseline period < 4 days;
Combined with severe anxiety/depression;
Suicidal tendencies or severe mental illness (bipolar disorder, schizophrenia, paranoid psychosis, etc.);
Edinburgh Pregnancy Depression Scale (EPDS) total score ≥ 15;
Have drug dependence or have taken anti-anxiety, anti-depression, sedative or hypnotic drugs for mental diseases within the past 3 months;
Participated in interventions such as meditation courses, childbirth yoga or cognitive behavioral therapy in the past 1 year;
Complicated with serious physical diseases such as heart failure and tumor;
Combined with sleep disorders such as severe obstructive sleep apnea that require further evaluation and treatment;
There is alcohol and cigarette dependence;
Shift work;
Severe visual or hearing impairment and unable to use mobile phones normally;
Physical illness with unstable condition, or illness itself that may interfere with cognitive behavioral therapy for insomnia.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zhaoxia Liang
Phone
+860571-87061501
Email
xiaozaizai@zju.edu.cn
12. IPD Sharing Statement
Learn more about this trial
Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia
We'll reach out to this number within 24 hrs